PRESS RELEASE published on 04/09/2025 at 14:10, 9 months 28 days ago Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments Immunic, Inc. announces pricing of $5.1 million registered direct offering led by Aberdeen Investments for clinical pipeline of therapies. Funds to be used for clinical trials and operations Registered Direct Offering Immunic Inc. Clinical Pipeline Thérapies Aberdeen Investments
BRIEF published on 04/01/2025 at 12:35, 10 months 6 days ago Immunic, Inc. Announces Participation in Key April Conferences Biotechnology Conférences Immunic Inc. Vidofludimus Calcium Neuroprotection
BRIEF published on 04/01/2025 at 12:35, 10 months 6 days ago Immunic, Inc. annonce sa participation aux principales conférences d'avril Biotechnologie Conférences Immunic Inc. Neuroprotection Vidofludimus Calcique
PRESS RELEASE published on 04/01/2025 at 12:30, 10 months 6 days ago Immunic, Inc. to Participate in Scientific and Industry Conferences in April Immunic, Inc. to participate in scientific and industry conferences in April, including American Academy of Neurology 2025 Annual Meeting and German Biotech Days 2025 Immunic Inc. Industry Conferences Scientific Conferences American Academy Of Neurology German Biotech Days
BRIEF published on 03/03/2025 at 12:35, 11 months 4 days ago Immunic to Join March Conferences to Present Research Biotechnology Investor Relations Conférences Antiviral Research Virology
BRIEF published on 03/03/2025 at 12:35, 11 months 4 days ago Immunic participera aux conférences de mars pour présenter ses recherches Biotechnologie Conférences Relations Avec Les Investisseurs Recherche Antivirale Virologie
PRESS RELEASE published on 03/03/2025 at 12:30, 11 months 4 days ago Immunic to Participate in Scientific and Investor Conferences in March Immunic to participate in scientific and investor conferences in March including the 34th Annual Meeting of the Society for Virology in Hamburg, Germany, and Leerink Partners Global Healthcare Conference in Miami Biotechnology Investor Conferences Clinical Pipeline Immunic Scientific Conferences
BRIEF published on 02/26/2025 at 12:35, 11 months 9 days ago Immunic partage des données prometteuses sur le vidofludimus calcique au Forum ACTRIMS 2025 Sclérose En Plaques Neuroprotection Vidofludimus Calcique Activation De Nurr1 Essai CALLIPER
BRIEF published on 02/26/2025 at 12:35, 11 months 9 days ago Immunic Shares Promising Data on Vidofludimus Calcium at ACTRIMS Forum 2025 Multiple Sclerosis Vidofludimus Calcium Neuroprotection Nurr1 Activation CALLIPER Trial
PRESS RELEASE published on 02/26/2025 at 12:30, 11 months 9 days ago Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple Sclerosis Immunic presents key data on vidofludimus calcium at ACTRIMS Forum 2025, highlighting its potential in multiple sclerosis. Phase 2 CALLIPER trial results expected in April Clinical Trial Multiple Sclerosis Immunic Vidofludimus Calcium ACTRIMS Forum 2025
Published on 02/07/2026 at 01:00, 1 day 8 hours ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 10 hours ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 11 hours ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 17 hours ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 19 hours ago Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/07/2026 at 21:00, 12 hours 15 minutes ago Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 16 hours 40 minutes ago The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 16 hours 55 minutes ago NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 13 hours ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 15 hours ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 18:22, 1 day 14 hours ago Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 1 day 14 hours ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 17 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 1 day 17 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 2 days 1 hour ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026